Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–8 of 8 results
Advanced filters: Author: Ram Savan Clear advanced filters
  • Ram Savan and colleagues report that two miRNAs known to suppress type 3 interferon (IFN) signaling also downregulate type 1IFN signaling in hepatitis C virus (HCV)-infected hepatocytes. The findings provide insights into the mechanisms by which antiviral IFN signaling is inhibited in HCV infection.

    • Abigail Jarret
    • Adelle P McFarland
    • Ram Savan
    Research
    Nature Medicine
    Volume: 22, P: 1475-1481
  • The autoinflammatory pathology associated with alteration of the ZBD domain of the RNA-editing enzyme ADAR1 is driven by signalling that is dependent on the nucleotide sensor ZBP1.

    • Nicholas W. Hubbard
    • Joshua M. Ames
    • Andrew Oberst
    Research
    Nature
    Volume: 607, P: 769-775
  • Innate lymphoid cell–derived cytokine IL-13 promotes the maintenance of intestinal stem cells through stabilization of β-catenin. The circular RNA circPan3 regulates mRNA encoding the cytokine receptor subunit IL-13Rα and downstream IL-13 signaling to stabilize the β-catenin pathway in intestinal stem cells.

    • Frank Soveg
    • Jakob von Moltke
    • Ram Savan
    News & Views
    Nature Immunology
    Volume: 20, P: 114-116
  • Interferon-λ (IFN-λ) curbs neutrophil-mediated intestinal inflammation by diminishing the production of reactive oxygen species and subsequent oxidative stress. This regulatory process is unique to IFN-λ and is independent of interferon-induced transcription and translation programs.

    • Emily A Hemann
    • Johannes Schwerk
    • Ram Savan
    News & Views
    Nature Immunology
    Volume: 18, P: 1061-1062